The DOI matches its Crossref record; 92 of the 93 references it cites were found in a registry or an index.
The Serotonin 5-HT2A Receptors Antagonist M100907 Prevents Impairment in Attentional Performance by NMDA Receptor Blockade in the Rat Prefrontal Cortex
Abstract
We investigated whether 5-HT2A receptors contribute to the control of attentional performance by glutamate NMDA receptor mechanisms in the medial prefrontal cortex (mPFC). We examined the effects of NMDA receptor blockade in the mPFC on attentional performance by infusing a competitive glutamate NMDA receptor antagonist, 3-(R)-2-carboxypiperazin-4-propyl-1-phosphonic acid (CPP) into the mPFC of rats performing a task of divided and sustained visual attention. The five-choice serial reaction time task provides indices of attentional functioning (% correct responses), executive control (measured by anticipatory and perseverative responses) and speed. A dose of 10 ng CPP injected bilaterally into the mPFC increased anticipatory and perseverative responding; 50 ng reduced accuracy. Increasing the stimulus duration alleviated the CPP-induced accuracy deficit but did not reduce its effects on anticipatory and perseverative responses. CPP at 50 ng caused motor hyperactivity whereas lower doses had no effect. [R-(+)-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidine-methanol] (M100907) (M100907), a 5-HT2A receptor antagonist, injected subcutaneously at 10 and 40 microg/kg, had no effect on accuracy but dose dependently reversed the impairment induced by 50 ng CPP. Both doses of M100907 completely abolished CPP-induced anticipatory but not perseverative over-responding. At the dose of 40 microg/kg M100907 reversed CPP-induced motor hyperactivity. This study provides evidence that the prefronto-cortical glutamate NMDA system may make an important contribution to the control of attention and executive functions. It also indicates that 5-HT2A receptors may serve to optimize attentional selectivity and improve some aspects of executive control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In non-stressed animals both competitive NMDA-R antagonists, such as (R)-CPP (Mirjana et al 2004) and non-competitive NMDA-R antagonists such as dizocilpine, and phencyclidine (Higgins et al 2003, Le Pen et al 2003) injected into the mPFC produce pronounced attentional performance deficits as measured by increase in omissions and latency for correct detection in the 5-CSRTT.”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Mirjana et al 2004
In the citing paper
“For example, (R)-CPP produced increased premature responding, indicating deficits in response inhibition (Mirjana et al 2004).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Mirjana et al 2004
In the citing paper
“Injecting M100907 subcutaneously reverses CPP-induced decreases in response inhibition (Mirjana et al 2004).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Mirjana et al 2004
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 26,755
Statistical Principles in Experimental Design
Myers, J. L., & Winer, B. J. (1964) · The American Journal of Psychology · doi:10.2307/1419292 · Cited by 8,058
Specific impairments of planning
Shallice, T. (1982) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1982.0082 · Cited by 3,741
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Exploring the Central Executive
Baddeley, A. (1996) · The Quarterly Journal of Experimental Psychology Section A · doi:10.1080/713755608 · Cited by 2,390
(1995) · Choice Reviews Online · doi:10.5860/choice.32-5931 · Cited by 2,311
Research works printed but not linked: 2
- Fuster JM (1989). The Prefrontal Cortex, 2nd edn. Raven Press: New York.
- Mishkin M (1964). Perseveration of central sets after frontal lesions in monkeys. In: Akert K (ed). The Frontal Granular Cortex and Behaviour. McGraw-Hill: New York.
Cited by
The neuropharmacology of impulsive behaviour
PATTIJ, T., & VANDERSCHUREN, L. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.01.002 · Cited by 473
Serotonin and Prefrontal Cortex Function: Neurons, Networks, and Circuits
Puig, M. V., & Gulledge, A. T. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8214-0 · Cited by 421
“In rats, where more invasive experiments can be implemented, both stimulation of 5-HT1A receptors or blockade of 5HT2A receptors in the PFC abolished attentional impairments induced by the NMDA receptor antagonist CPP [171, 172].”
BackgroundThe role of serotonin 5-HT2A receptors in memory and cognition
Zhang, G., & Stackman, R. W. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00225 · Cited by 382
“Fear conditioning taxes a well-defined neural circuit within the amygdala, which in turn interacts with the hippocampus, anterior cingulate, or the PFC, depending on the elements of the conditioning session and the stage of memory processing (Zelikowsky et al., 2014).”
BackgroundInfluentialCarli, M., Baviera, M., Invernizzi, R. W., & Balducci, C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300893 · Cited by 187
“Interestingly, opposite behavioral effects of 8-OH-DPAT were often reported depending on whether the drug was administered directly into the DR or into its projecting areas (Carli et al, 1995, 1998; Warburton et al, 1997).”
BackgroundResultInfluentialSelf-citationPerry, J. L., Joseph, J. E., Jiang, Y., Zimmerman, R. S., Kelly, T. H., Darna, M., Huettl, P., Dwoskin, L. P., & Bardo, M. T. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.09.001 · Cited by 180
Prefrontal cortex executive processes affected by stress in health and disease
Girotti, M., Adler, S. M., Bulin, S. E., Fucich, E. A., Paredes, D., & Morilak, D. A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.004 · Cited by 176
Ishiyama, T., Tokuda, K., Ishibashi, T., Ito, A., Toma, S., & Ohno, Y. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.058 · Cited by 165
The role of serotonin in the regulation of patience and impulsivity
Miyazaki, K., Miyazaki, K. W., & Doya, K. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8232-6 · Cited by 162
“extracellular glutamate [65, 66] and increase premature responses in the 5-CSRTT [67].”
BackgroundSchmaal, L., Veltman, D. J., Nederveen, A. J., van den Brink, W., & Goudriaan, A. E. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.66 · Cited by 162
“For instance, selective and nonselective NMDA receptor antagonists have been shown to increase impulsive behavior in animal models (Higgins et al, 2003; Mirjana et al, 2004).”
BackgroundRobinson, E. S. J., Dalley, J. W., Theobald, D. E. H., Glennon, J. C., Pezze, M. A., Murphy, E. R., & Robbins, T. W. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301636 · Cited by 166
Murphy, E. R., Dalley, J. W., & Robbins, T. W. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2068-3 · Cited by 145
“The present results are globally consistent with those of a recent study investigating the effects of infusions of the same doses of (R)-CPP into a single site in the mPFC ( Carli et al. 2004 ).”
BackgroundResultInfluentialAmitai, N., & Markou, A. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.004 · Cited by 144
ENOMOTO, T., ISHIBASHI, T., TOKUDA, K., Ishiyama, T., TOMA, S., & Itô, A. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.08.012 · Cited by 132
Doyle, O., Simoni, S. D., Schwarz, A. J., Brittain, C., O’Daly, O., Williams, S., & Mehta, M. A. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201665 · Cited by 116
“, 2011) and cognitive function (Varty et al., 1999; Mirjana et al., 2004; Didriksen et al., 2007), deficits thought to be the result of a frontal hyperglutamatergic state.”
BackgroundLeiser, S. C., Li, Y., Pehrson, A. L., Dale, E., Smagin, G. N., & Sánchez, C. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500340j · Cited by 116
Fletcher, P. J., Rizos, Z., Noble, K., & Higgins, G. A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.025 · Cited by 109
Hoerst, M., Weber-Fahr, W., Tunc-Skarka, N., Ruf, M., Bohus, M., Schmahl, C., & Ende, G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.93 · Cited by 97
“By infusions of CPP into the medial prefrontal and infralimbic regions, altered glutamate neurotransmission associated with impulsive action was observed.(64,66,67) The association of the glutamate signal and dissociation is of particular interest, since the ACC plays an important role in the mediation of dissociative…”
BackgroundMethodLarge, C. H. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107077712 · Cited by 98
“, 1999), and impairment of attention (Mirjana et al., 2004).”
BackgroundInhibitory Control Deficits in Rats with Ventral Hippocampal Lesions
Abela, A. R., Dougherty, S. D., Fagen, E. D., Hill, C. J. R., & Chudasama, Y. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs121 · Cited by 111
Bidirectional regulation of novelty-induced behavioral inhibition by the endocannabinoid system
Lafenêtre, P., Chaouloff, F., & Marsicano, G. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.014 · Cited by 106
Alterations of dopamine and serotonin transmission in schizophrenia
Remington, G. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00906-0 · Cited by 95
“…has also been shown to attenuate PPI deficits observed in dopamine transporter (DAT) knockout mice (Barr et al., 2004), in addition to deficits in attention and executive control, as measured using a five-choice serial reaction time task, produced by NMDA receptor antagonism (Mirjana et al., 2004).”
MethodSerotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex
Nocjar, C., Alex, K. D., Sonneborn, A., Abbas, A. I., Roth, B. L., & Pehek, E. A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.050 · Cited by 85
“The receptors also oppositely regulate behavior controlled by the mPFC (Williams et al., 2002;Winstanley et al., 2004;Mirjana et al., 2004;Ramos et al., 2005;Bubar and Cunningham, 2006;Carli et al., 2006;Pentkowski and Neisewander, 2008;Jensen et al., 2010;Pockros et al., 2011;Cunningham et al.,…”
BackgroundGreco, B., Invernizzi, R. W., & Carli, M. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2127-9 · Cited by 86
“Forebrain 5-HT appeared to be selectively involved in anticipatory “impulsive” responding in a 5-CSRT task (Dalley et al. 2002; Harrison et al. 1997; Puumala and Sirvio 1998), probably through opposite actions on 5-HT2A and 5-HT2C receptors ( Carli et al. 2004; Higgins et al. 2003b; Koskinen et al. 2000).”
BackgroundResultInfluentialSelf-citationCeglia, I., Carli, M., Baviera, M., Renoldi, G., Calcagno, E., & Invernizzi, R. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02704.x · Cited by 79
“The fact that the same doses of M100,907 that prevent deficits in attentional performance (Carli et al. 2004) attenuate the effect of CPP on extracellular GLU (present study) suggests that the stimulation of GLU release may play a role in the attentional performance deficits caused by CPP.”
BackgroundInfluentialSelf-citationFinlay, J. M., Dunham, G. A., Isherwood, A. M., Newton, C. J., Nguyen, T. V., Reppar, P. C., Snitkovski, I., Paschall, S. A., & Greene, R. W. (2014) · Brain Research · doi:10.1016/j.brainres.2014.10.037 · Cited by 86
“Using this approach, investigators have observed that acute NMDAR blockade in the rat mPFC increases premature responding (Mirjana et al., 2004; Murphy et al., 2005, 2012) and, under some circumstances, perseverative responding (Mirjana et al., 2004).”
BackgroundCarli, M., & Invernizzi, R. W. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00058 · Cited by 86
Self-citationThe potential role of lamotrigine in schizophrenia
Large, C. H., Webster, E. L., & Goff, D. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0020-9 · Cited by 69
“As discussed earlier, drugs that negatively modulate glutamate transmission, such as 5-HT2a antagonists (Mirjana et al. 2004; Ceglia et al. 2004) and mGluR2/3 agonists (Schoepp and Marek 2002; Carter et al.”
InfluentialMetabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition
Marek, G. J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.058 · Cited by 77
“…of rats performing on the 5- CSRTT or the DRL 72-s schedule either when administered alone or with NMDA receptor antagonists that impair cortical function (Ardayfio et al., 2008; Carli et al., 2004; 2006; Higgins et al., 2003; Marek et al., 2005; Winstanley et al., 2003; Winstanley et al., 2004).”
BackgroundMethodHiggins, G. A., Ballard, T. M., Enderlin, M., Haman, M., & Kemp, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2203-9 · Cited by 74
Agnoli, L., Mainolfi, P., Invernizzi, R. W., & Carli, M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.236 · Cited by 80
Self-citationCarli, M., Calcagno, E., Mainolfi, P., Mainini, E., & Invernizzi, R. W. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2065-7 · Cited by 73
“In rats, the disruptive effects of acute NMDA receptor antagonists on motor activity, working memory, and attention may be associated with the ability to raise extracellular GLU concentrations in the mPFC (Ceglia et al. 2004; Mirjana et al. 2004; Moghaddam et al. 1997; Moghaddam and Adams 1998).”
BackgroundMethodInfluentialSelf-citationHiggins, G. A., Grzelak, M. E., Pond, A. J., Cohen-Williams, M. E., Hodgson, R. A., & Varty, G. B. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.07.013 · Cited by 64
Zhang, C., & Marek, G. J. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.009 · Cited by 65
“Systemic or local (mPFC) administration of the 5-HT2A receptor antagonist M100907 has also been shown to block increased locomotor activity or motor impulsivity induced by either systemic or local (mPFC) infusions of NMDA receptor antagonists (Carli et al., 2004; Gleason and Shannon, 1997; Higgins et al., 2003; Martin…”
BackgroundCalcagno, E., Carli, M., & Invernizzi, R. W. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03600.x · Cited by 54
“1987), injected intracortically, impaired attentional performance in the five-choice serial reaction time task (5-CSRTT) (Mirjana et al. 2004) and raised extracellular GLU (Ceglia et al.”
BackgroundInfluentialSelf-citationGreco, B., & Carli, M. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.02.002 · Cited by 61
Cottone, P., Iemolo, A., Narayan, A. R., Kwak, J., Momaney, D., & Sabino, V. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2898-3 · Cited by 54
“Indeed, microinfusion of the competitive NMDA receptor antagonist 3-((R)-2carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP) into fronto-cortical brain regions has been shown to reduce accuracy, as well as to increase omission errors and perseverative responding in rats performing the 5-CSRTT (Baviera et al. 2008;…”
Schmaal, L., Goudriaan, A. E., van der Meer, J. N., van den Brink, W., & Veltman, D. J. (2012) · Brain and Behavior · doi:10.1002/brb3.74 · Cited by 55
“Published by Wiley Periodicals, Inc. sive behavior in animal models (Higgins et al. 2003; Mirjana et al. 2004).”
BackgroundPozzi, L., Baviera, M., Sacchetti, G., Calcagno, E., Balducci, C., Invernizzi, R. W., & Carli, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.11.060 · Cited by 49
Self-citationTolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice
Buchborn, T., Lyons, T., & Knöpfel, T. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00017 · Cited by 51
“By enhancing cortical glutamate release, 5-HT2A receptors may modulate cognitive processes, such as working memory and attention (Williams et al., 2002; Mirjana et al., 2004).”
BackgroundTerry, A. V., Buccafusco, J. J., Schade, R. F., Vandenhuerk, L., Callahan, P. M., Beck, W. D., Hutchings, E. J., Chapman, J., Li, P., & Bartlett, M. G. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.043 · Cited by 51
Baviera, M., Invernizzi, R. W., & Carli, M. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0959-9 · Cited by 46
“Interestingly, improvements in accuracy and anticipatory responding similar to those reported here after clozapine were achieved by blockade of 5-HT2A receptors in the mPFC (Carli et al. 2006; Mirjana et al. 2004).”
BackgroundResultInfluentialSelf-citationMillan, M. J., & Brocco, M. (2008) · Therapies · doi:10.2515/therapie:2008041 · Cited by 47
Semenova, S., & Markou, A. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.003 · Cited by 48
“…deficits were also seen after systemic or central administration of different NMDA receptor antagonists (Higgins et al., 2003; Murphy et al., 2005; Mirjana et al., 2004), but their effects on accuracy were more robust compared to MPEP indicating that the mGluR5 may play a modulatory role in…”
BackgroundColeman, L. G., Jarskog, L. F., Moy, S. S., & Crews, F. T. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.04.017 · Cited by 45
“…CPP (50ng/μl) directly into the adult PFC display made four times as many anticipatory responses and three times as many perseverative responses in the 5-Choice Serial Reaction Time task (5-CSRT) than controls signifying increased impulsive behavior (Baviera et al., 2008; Mirjana et al., 2004).”
BackgroundMethodInfluentialZhang, G., Cinalli, D., Cohen, S. J., Knapp, K. D., Rios, L. M., Martínez-Hernández, J., Luján, R., & Stackman, R. W. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.033 · Cited by 41
Shimizu, S., Mizuguchi, Y., & Ohno, Y. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113129990088 · Cited by 47
“, MK-801 and phencyclidine) [60, 61].”
Rompala, G. R., Zsiros, V., Zhang, S., Kolata, S., & Nakazawa, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061278 · Cited by 50
Wilson, C. A., Schade, R., & Terry, A. V. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.040 · Cited by 40
Agnoli, L., & Carli, M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2581-0 · Cited by 46
“Similar impairments have been reported after blockade of NMDA receptors by a competitive antagonist 3-(R)-2-carboxypiperazin-4-phosphonic acid (CPP) in the mPFC or dm-STR (Agnoli and Carli 2011; Mirjana et al. 2004; Murphy et al. 2005).”
InfluentialPolli, F. S., Scharff, M. B., Ipsen, T. H., Aznar, S., Kohlmeier, K. A., & Andreasen, J. T. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172951 · Cited by 41
Peddie, C. J., Davies, H. A., Colyer, F. M., Stewart, M. G., & Rodríguez, J. J. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.03.003 · Cited by 43
“M100907 can counteract the effects of N-methyl-D-aspartate (NMDA) receptor antagonists such as MK-801 and 3-((R)-2-carboxypiperazin-4-yl)propyl-1-phosphoric acid (Carlsson et al., 1999; Ceglia et al., 2004; Higgins et al., 2003; Mirjana et al., 2004; Varty et al., 1999).”
Dawson, N., McDonald, M., Higham, D. J., MORRIS, B. J., & Pratt, J. A. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.26 · Cited by 44
“…neuromodulatory systems can attenuate the disruptive effects of NMDA receptor antagonists on PFC-dependent cognitive processes (Metzer et al, 2011; Mirjana et al, 2004), PFC physiology (Jentsch et al, 1998), and other translationally relevant behaviors (Bakshi and Geyer, 1997; Stuchlik et al,…”
BackgroundCalcagno, E., Carli, M., Baviera, M., & Invernizzi, R. W. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05789.x · Cited by 39
“…were prevented by blockade of 5-HT2A receptor with the selective antagonist, (R)-(+)-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]4-piperidine methanol, M100907 (Ceglia et al. 2004; Mirjana et al. 2004) or stimulation of the cortical 5-HT1A receptor (Calcagno et al. 2006; Carli et al. 2006).”
BackgroundInfluentialSelf-citationIsherwood, S. N., Pekcec, A., Nicholson, J. R., Robbins, T. W., & Dalley, J. W. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3984-0 · Cited by 37
Stephens, E. K., Avesar, D., & Gulledge, A. T. (2014) · Frontiers in Neural Circuits · doi:10.3389/fncir.2014.00097 · Cited by 44
Quarta, D., Naylor, C. G., Morris, H. V., Patel, S., Genn, R. F., & Stolerman, I. P. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.023 · Cited by 36
Neuropharmacology of attention
Burk, J. A., Blumenthal, S. A., & Maness, E. B. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.008 · Cited by 35
“Furthermore, intra-mPFC infusions of other NMDA antagonists, M100907 and 3-((R)-2carboxypiperazin-4-yl)-propyl-1-phosphonic acid [(R)-CP], result in attentional impairments in performance on the 5CSRTT (Mirjana et al., 2004; Murphy et al., 2005).”
BackgroundAntagonism at serotonin 5-HT2A receptors modulates functional activity of frontohippocampal circuit
Gozzi, A., Crestan, V., Turrini, G., Clemens, M., & Bifone, A. (2010) · Psychopharmacology · doi:10.1007/s00213-009-1772-4 · Cited by 33
Serotonin and inhibitory response control: Focusing on the role of 5-HT1A receptors
Pattij, T., & Schoffelmeer, A. N. M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.05.064 · Cited by 32
Drueke, B., Baetz, J., Boecker, M., Moeller, O., Hiemke, C., Gründer, G., & Gauggel, S. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1649-6 · Cited by 33
“Animal studies provide evidence for 5-HT influence on attention: the selective 5-HT2A receptor antagonist M100907 improves attentional performance in rats performing a five-choice serial reaction time (5-CSRT) task ( Mirjana et al. 2004 ).”
BackgroundAmargós‐Bosch, M., Adell, A., & Artigas, F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04532.x · Cited by 31
“…in rats (Wadenberg et al. 2000) and both M100907 and prazosin have been reported to block behavioral effects of hallucinogenic compounds such as DOI or non-competitive NMDA receptor antagonists in rats (Schreiber et al. 1995; Dursun and Handley 1996; Varty et al. 1999; Mirjana et al. 2004).”
BackgroundTolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe
Herian, M., Skawski, M., Wojtas, A., Sobocińska, M. K., Noworyta, K., & Gołembiowska, K. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05860-5 · Cited by 26
“By enhancing glutamate release, 5-HT2A receptors may control cognitive processes, such as attention, executive functions, and working memory (Mirjana et al. 2004).”
BackgroundAuclair, A. L., Besnard, J., Newman‐Tancredi, A., & Depoortère, R. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.01.005 · Cited by 30
Marek, G. J. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78006-0 · Cited by 25
Deficits in LTP Induction by 5-HT2A Receptor Antagonist in a Mouse Model for Fragile X Syndrome
Xu, Z., Yang, Q., Ma, L., Liu, S., Chen, G.-S., Wu, Y., Li, X., Liu, G., & Zhao, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048741 · Cited by 31
Liu, X., Li, L., Li, J., Tang, J., Rong, J., Liu, B., & Hu, Z. (2017) · Brain and Behavior · doi:10.1002/brb3.769 · Cited by 27
Yu, W., Yen, Y.-C., Lee, Y., Tan, S., Xiao, Y., Lokman, H., Ting, A. K. T., Ganegala, H. E. W., Kwon, T., Ho, W., et al. (2019) · Molecular Brain · doi:10.1186/s13041-019-0452-5 · Cited by 30
Marek, G. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.03.005 · Cited by 25
“Activation of 5-HT2A receptors has been found to increase motoric impulsivity while blockade of 5-HT2A receptors appears to enhance the ability of animals to wait before making a response when performing on DRL 72-s schedules (Ardayfio et al., 2008; Carli et al., 2004; Winstanley et al., 2004).”
BackgroundCONSCIOUSNESS AND THE STRUCTURE OF MATTER
MacGregor, R. J., & Vimal, R. L. P. (2008) · Journal of Integrative Neuroscience · doi:10.1142/s0219635208001733 · Cited by 22
“The neural circuitry [2,3,20,48–51,60,64–68,73,76,81,84,86,87] and associated neuroglial metabolism [19,47,60,61] of the vertebrate nervous system are likely candidate structural levels for the active manifestations of consciousness (Sec.”
BackgroundInfluentialCarli, M., Calcagno, E., Mainini, E., Arnt, J., & Invernizzi, R. W. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2066-6 · Cited by 20
“These effects were prevented by the blockade of 5-HT2A receptors (Ceglia et al. 2004; Mirjana et al. 2004 ) or stimulation of 5-HT1A and 5-HT2C receptors (Calcagno et al. 2009; Carli et al. 2006).”
BackgroundInfluentialSelf-citationHunt, M. J., Olszewski, M., Piasecka, J., Whittington, M. A., & Kasicki, S. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4073-0 · Cited by 20
“…subtypes can block NMDA receptor antagonist-induced hyperlocomotion (Gleason and Shannon 1997) and attentional impairments (Higgins et al. 2003; Mirjana et al. 2004) and may reverse dysfunctional glutamatergic transmission produced by NMDA receptor antagonists (Ceglia et al. 2004; McOmish et…”
NMDA antagonist and antipsychotic actions in cortico-subcortical circuits
Kargieman, L., Santana, N., Mengod, G., Celada, P., & Artigas, F. (2008) · Neurotoxicity Research · doi:10.1007/bf03033805 · Cited by 22
“Indeed, the 5-HT 2A receptor antagonist M100907 antagonized some neurochemical and behavioral effects of NMDA receptor blockade (Martin et al., 1997; Mirjana et al., 2004; Amargos-Bosch et al., 2007), yet discrepant results have also been reported (Adams and Moghaddam, 2001).”
BackgroundAgnoli, L., & Carli, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.04.044 · Cited by 27
Wang, Y., Yin, F., Guo, H., Zhang, J., Yan, P., & Lai, J. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx010 · Cited by 20
“It has been shown that acute NMDA receptor dysfunction in the rat medial FC impairs attention and behavioral inhibition in the 5-CSRTT (Mirjana et al., 2004; Pozzi et al., 2011).”
BackgroundAttenuation of pharmacologically-induced attentional impairment by methylphenidate in rats
Rezvani, A. H., Kholdebarin, E., Cauley, M. C., Dawson, E. A., & Levin, E. D. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.11.005 · Cited by 22
Nikiforuk, A., Hołuj, M., Potasiewicz, A., & Popik, P. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.04.030 · Cited by 17
Marek, G. J., Day, M., & Hudzik, T. J. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.229922 · Cited by 17
Shahidi, ., Komaki, A., Sadeghian, R., & Asl, S. S. (2018) · Brain Research · doi:10.1016/j.brainres.2018.07.030 · Cited by 21
Pozzi, L., Greco, B., Sacchetti, G., Leoni, G., Invernizzi, R. W., & Carli, M. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1738-6 · Cited by 17
Self-citationBarlow, R. L., Dalley, J. W., & Pekcec, A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4836-5 · Cited by 15
“Systemic or directed administration of N-methyl-D-aspartate (NMDA) receptor antagonists , such as MK-801, phencyclidine (PCP), and 3-(2-carboxypiperazine-4yl)propyl-1-phosphoric acid (CPP), enhance impulsivity on the 5-CSRTT (Fletcher et al. 2011; Greco et al. 2005; Mirjana et al. 2004).”
BackgroundAssessment of attention and inhibitory control in rodent developmental neurotoxicity studies
Driscoll, L. L., & Strupp, B. J. (2014) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2014.09.001 · Cited by 14
Chien, T.-H., Chan, M., Tang, Y.-C., & Chen, H. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0137-x · Cited by 13
“It is noteworthy that in addition to NMDA receptors, dopaminergic (Verma and Kulkarni 1992), serotoninergic (Carlsson et al. 1999; Mirjana et al. 2004), cholinergic, and non-NMDA glutamatergic systems (Adams and Moghaddam 1998; Moghaddam et al. 1997; Takahata and Moghaddam 2003) appear to be…”
BackgroundDavis-Reyes, B. D., Campbell, V. M., Land, M. A., Chapman, H. L., Stafford, S. J., & Anastasio, N. C. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.07.007 · Cited by 12
Isherwood, S. N., Robbins, T. W., Dalley, J. W., & Pekcec, A. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14290 · Cited by 11
Marek, G. J. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.01.003 · Cited by 10
“Activation of 5-HT2A receptors in rodents appears to increase certain forms of impulsivity and interfere with arousal and attention (Carli et al., 2004; Koskinen et al., 2000; Winstanley et al., 2003; Winstanley et al., 2004).”
BackgroundCarr, M. R., Vries, T. J. D., & Pattij, T. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000425 · Cited by 9
“However, these manipulations still indiscriminately affected multiple cells types within the region, that is, local interneurons and output pyramidal neurons alike (Mirjana et al., 2004; Murphy et al., 2005; Carli and Invernizzi, 2014; Cohen et al., 2016).”
BackgroundChagraoui, A., Santillan, L. A. H., Bocian, R., Cohen, S. J., Ruíz, Y. E. S., Knox, M., Kaźmierska, P., Zimoń, W., Stackman, R. W., Flores‐Hernández, J., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118742 · Cited by 6
Solomon, M. B., Yegla, B., Newcorn, J. H., Maletic, V., Rubin, J. S., & Robbins, T. W. (2025) · Clinical Drug Investigation · doi:10.1007/s40261-025-01473-4 · Cited by 11
“…on attentional accuracy, as well as impulsive responding, produced by the NMDA receptor antagonist 3-(2-carboxypiperazin-4-yl)propyl-1-phos-phonic acid (CPP) could be reversed by treatment with either 8-OHDPAT or the 5-HT2A receptor antagonist M-100907 when infused into rat mPFC [211, 212].”
Marek, G. J. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.04.068 · Cited by 7
“5-HT2A receptor activation in rodents appears increases motor impulsivity and interferes with arousal and attention [6-9].”
BackgroundPrefrontal cortical neuregulin-ErbB modulation of inhibitory control in rats
Loos, M., Schetters, D., Hoogeland, M. E., Spijker, S., Vries, T. J. D., & Pattij, T. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.015 · Cited by 8
“Conversely, in line with the NMDA receptor hypofunction hypothesis of schizophrenia (Gilmour et al., 2012), antagonism of NMDA receptors in the mPFC has been shown to increase premature responding in the 5-CSRTT (Mirjana et al., 2004; Murphy et al., 2005, 2012).”
BackgroundEcheazarra, L., Barrondo, S., del Caño, G. G., Río, I. B., Huguet, J. E., Puente, N., Aretxabala, X., Montaña, M., de Jesús, M. L., González‐Burguera, I., et al. (2022) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2022.1004702 · Cited by 5
“Consistently, in standard rodent animals, the systemic blockade of glutamatergic transmission leads to an increase in impulsive behavior (Mirjana et al., 2004; Floresco et al., 2008).”
BackgroundBaenas, I., Solé‐Morata, N., Granero, R., Fernández‐Aranda, F., Pujadas, M., Mora‐Maltas, B., Lucas, I., Gómez‐Peña, M., Moragas, L., del Pino‐Gutiérrez, A., et al. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.2460 · Cited by 2
Yazıcı, K., & Yazıcı, A. (2010) · Cited by 1
Gil, J. L. (2009) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Boosting impulse control in addiction. Pharmacological neuroimaging studies
Schmaal, L. (2013) · UvA-DARE (University of Amsterdam)
Benkő, A. (2012) · Semmelweis University Repository (Semmelweis University) · doi:10.14753/se.2012.1655 · Cited by 1
Probing brain function with pharmacological MRI
Gozzi, A. (2011)
Coleman, L. G. (2010) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/ddyv-cr38
Investigating the modulation of methylphenidate’s effects on impulsivity by fluoxetine
Chittenden, R. (2015) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17019209
Chandini, M., Prasuna, P. V., & Pujitha, C. V. (2016) · INFM-OAR (INFN Catania) · doi:10.5281/zenodo.189100
Metadata
- Authors
- Mirjana, C., Baviera, M., Invernizzi, R. W., & Balducci, C.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Venue
- Neuropsychopharmacology
- Published
- 2004-05-05
- Volume
- 29
- Issue
- 9
- Pages
- 1637-1647
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2044977985
- Cited by
- 102
- References
- 93
- Citations by year
- 2026: 2 · 2025: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 6 · 2017: 3 · 2016: 3 · 2015: 8 · 2014: 6 · 2013: 4 · 2012: 10
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Update notices
- erratum (2004-12-22)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministero dell’Istruzione, dell’Università e della Ricerca (RBAU01ZS5C)
- Ministero dell'Università e della Ricerca
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- 5-HT2A receptor antagonism, M100907, NMDA receptor blockade, CPP, attentional performance, sustained visual attention, divided attention, medial prefrontal cortex, executive function, perseverative responding, motor hyperactivity, glutamate, serotonin
- MeSH terms
- Animals, Attention, Dose-Response Relationship, Drug, Fluorobenzenes, Injections, Subcutaneous, Male, Microinjections, Motor Activity, Piperazines, Piperidines, Psychomotor Performance, Reaction Time, Serial Learning, Serotonin Antagonists, Receptors, N-Methyl-D-Aspartate, Prefrontal Cortex, Excitatory Amino Acid Antagonists, Receptor, Serotonin, 5-HT2A, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.